Quarterly Results

  • Company Name :
Hikal Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 524735
  • NSE Symbol:
  • HIKAL
  • P/E(TTM):
  • 62.08
  • ISIN Demat:
  • INE475B01022
  • Div & Yield%:
  • 0.32
  • EPS(TTM):
  • 6.04
  • Book Value(₹):
  • 97.60
  • Market Cap(₹Cr.):
  • 4,623.16
  • Face Value(₹):
  • 2.00
Quarters :  
Particulars December 2024 ( Cr)September 2024 ( Cr)June 2024 ( Cr)
Gross Sales 438.90 450.80 403.80
Excise Duty 0.00 0.00 0.00
Net Sales 438.90 450.80 403.80
Other Operating Income 8.80 2.10 3.00
Other Income 3.60 0.40 0.50
Total Income 451.30 453.30 407.30
Total Expenditure 375.50 378.20 348.70
PBIDT 75.80 75.10 58.60
Interest 18.70 18.80 19.80
PBDT 57.10 56.30 38.80
Depreciation 33.20 31.70 31.80
Tax 4.50 6.70 1.50
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax 2.10 -0.20 0.30
Reported Profit After Tax 17.30 18.10 5.20
Extra-ordinary Items 0.00 0.00 0.00
Adjusted Profit After Extra-ordinary item 17.30 18.10 5.20
EPS (Unit Curr.) 1.40 1.47 0.42
EPS (Adj) (Unit Curr.) 1.40 1.47 0.42
Calculated EPS (Unit Curr.) 1.40 1.47 0.42
Calculated EPS (Adj) (Unit Curr.) 1.40 1.47 0.42
Calculated EPS (Ann.) (Unit Curr.) 5.60 5.86 1.68
Calculated EPS (Adj) (Ann.) (Unit Curr.) 5.60 5.86 1.68
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 30.00 0.00 0.00
Equity 24.70 24.70 24.70
Reserve & Surplus 0.00 0.00 0.00
Face Value 2.00 2.00 2.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 17.27 16.66 14.51
PBDTM(%) 13.01 12.49 9.61
PATM(%) 3.94 4.02 1.29